(HALO) Halozyme Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Halozyme Therapeutics | (HALO) share price targets
Complete technical analysis of Halozyme Therapeutics (HALO) by charts plus indicators, forecast predictions and share price targets for Halozyme Therapeutics (HALO)
Halozyme Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-10-27 View latest technical analysis
10 day averaged volume of Halozyme Therapeutics is 1692650
| Date | Daily Closing Price | Open | High | Low | Volume |
| 27 Mon Oct 2025 | 65.85 | 66.80 | 66.99 | 65.56 | 0.794 times |
| 24 Fri Oct 2025 | 66.15 | 66.99 | 67.28 | 66.11 | 0.409 times |
| 23 Thu Oct 2025 | 66.89 | 65.99 | 66.98 | 65.63 | 0.845 times |
| 22 Wed Oct 2025 | 65.77 | 67.03 | 67.36 | 65.76 | 0.799 times |
| 21 Tue Oct 2025 | 66.88 | 66.53 | 67.03 | 65.96 | 1.022 times |
| 20 Mon Oct 2025 | 66.47 | 67.07 | 67.26 | 65.14 | 0.838 times |
| 17 Fri Oct 2025 | 67.03 | 66.97 | 67.54 | 66.18 | 1.324 times |
| 16 Thu Oct 2025 | 66.88 | 66.33 | 67.31 | 65.65 | 0.995 times |
| 15 Wed Oct 2025 | 66.36 | 67.42 | 67.62 | 65.64 | 1.257 times |
| 14 Tue Oct 2025 | 66.65 | 64.80 | 68.00 | 64.80 | 1.534 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 64.6 as stoploss in an intra day buy trade for a target of 67.33. However, stock will show a bearish move below 64.6.
Share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Target | 51.06 |
| Downside Target | 56.32 |
| Downside Target | 58.53 |
| Downside Target | 61.75 |
| Downside Target | 63.78 |
| Upside Target | 66.99 |
| Upside Target | 68.04 |
| Upside Target | 69.46 |
| Upside Target | 71.50 |
| Upside Target | 74.07 |
| Upside Target | 76.30 |
| Upside Target | 79.50 |
Intraday share price targets for Halozyme Therapeutics (HALO)
| Target Type | Value |
| Downside Intraday Target | 65.28 |
| Downside Intraday Target | 64.7 |
| Upside Intraday Target | 66.71 |
| Upside Intraday Target | 67.56 |
| Upside Intraday Target | 66.13 |
Weekly technical analysis of Halozyme Therapeutics (HALO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 27 Mon Oct 2025 | 65.85 | 66.80 | 66.99 | 65.56 | 0.203 times |
| 24 Fri Oct 2025 | 66.15 | 67.07 | 67.36 | 65.14 | 0.643 times |
| 17 Fri Oct 2025 | 67.03 | 64.26 | 68.00 | 64.10 | 1.102 times |
| 10 Fri Oct 2025 | 64.10 | 69.15 | 69.46 | 63.78 | 0.744 times |
| 03 Fri Oct 2025 | 68.98 | 73.75 | 76.30 | 68.04 | 1.224 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Halozyme Therapeutics (HALO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 27 Mon Oct 2025 | 65.85 | 75.20 | 76.30 | 63.78 | 0.848 times |
| 30 Tue Sep 2025 | 73.34 | 71.78 | 79.50 | 71.50 | 0.929 times |
| 29 Fri Aug 2025 | 73.15 | 59.82 | 74.07 | 58.53 | 1.497 times |
| 31 Thu Jul 2025 | 59.97 | 51.78 | 61.75 | 51.78 | 0.533 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Halozyme Therapeutics (HALO)
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.56 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a short to mid term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Halozyme Therapeutics ( (HALO) ) based on a mid to longer term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
ADX buy sell signal for Halozyme Therapeutics stock for short term is SELL. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Halozyme Therapeutics in short term and the sell signal is strong.
Halozyme Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Halozyme Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Halozyme Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 66.56 and Halozyme Therapeutics (HALO) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Halozyme Therapeutics (HALO) stock. Volume based technical analysis of Halozyme Therapeutics (HALO) stock is negative.
Halozyme Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.